openPR Logo
Press release

Transdermal Drug Delivery Systems Market could be worth US$ 51,949.74 Mn by 2030, says The Insight Partners

10-26-2023 11:52 AM CET | Health & Medicine

Press release from: The Insight Partners

Transdermal Drug Delivery System Market

Transdermal Drug Delivery System Market

According to our latest study on "Transdermal Drug Delivery Systems Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis" the market is expected to grow from US$ 37,230.28 million in 2022 and is expected to reach US$ 51,949.74 million by 2030; it is anticipated to record a CAGR of 4.3% from 2022 to 2030. The report highlights the key factors driving the transdermal drug delivery systems market growth and prominent players with their developments in the market.

Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00002894/?utm_source=OpenPR&utm_medium=10129

Transdermal drug delivery systems are dosage forms actively used to deliver a therapeutically effective amount of drug across a patient's skin. It is a type of medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Transdermal drug delivery systems deliver the drug at a controlled rate to the systemic circulation.

Based on product, the transdermal drug delivery system market is segmented into transdermal patches, transdermal gels, transdermal sprays, and others. The transdermal patch segment is further segmented into drug-in-adhesive patches, reservoir membrane patches, matrix patches, and vapor patches. The transdermal patches segment held the largest share of the market in 2022, while transdermal gels is anticipated to register the highest CAGR during 2022-2030. A transdermal patch is a drug delivery system attached to a patient's skin to deliver medication through the skin. The transdermal drug delivery system market, by application, has been segmented into cardiovascular diseases, central nervous system disorders, hormonal applications, pain management, and other applications. The market for the pain management segment is sub-segmented into opioid application and non-opioid application.

The market for hormonal application segment is further segmented into transdermal estrogen therapy and testosterone replacement therapy. The pain management segment held the largest share of the market in 2022. The central nervous system disorders segment is expected to register the highest CAGR in the market during 2022-2030. Based on the distribution channel, the transdermal drug delivery system market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital pharmacies segment held the largest share of the market in 2022. However, the retail pharmacies segment is expected to register the highest CAGR in the market during 2022-2030.

Novartis AG, Johnson & Johnson, GSK Plc, Viatris Inc, Boehringer Ingelheim International GmbH, Luye Pharma Group Ltd, Hisamitsu Pharmaceutical Co Inc, Lavipharm SA, Purdue Pharma LP, and UCB SA are among the leading companies operating in the global Transdermal Drug Delivery Systems market.

Companies operating in the transdermal drug delivery systems market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the transdermal drug delivery systems market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall transdermal drug delivery systems market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.

A few of the significant developments by key market players are listed below.
• In October 2023, Novartis completed the Spin-off of Sandoz, its Generics and Biosimilars business. Novartis executed the separation of the Sandoz business to create an independent company by way of a 100% Spin-off.
• In December 2022, Luye Pharma Group held an offline product launch conference in Shanghai, together with an online event, to announce the launch of Ruoxinlin (Toludesvenlafaxine Hydrochloride Extended-Release Tablets) in China. Ruoxinlin is China's first-class 1 innovative chemical drug independently developed locally for the treatment of Major Depressive Disorder (MDD) and protected by intellectual property rights. The drug provides a powerful new option for patients, bringing the treatment of MDD to a new level.
• In February 2021, Luye Pharma Group announced that its subsidiary Luye Pharma Switzerland AG has entered into an agreement with Towa Pharmaceutical Co Ltd (Towa), the terms of which grant Towa exclusive rights to the development and commercialization of Rivastigmine Multi-Day Transdermal Patch (Rivastigmine MD) in Japan. Rivastigmine MD, created by Luye Pharma, uses a cutting-edge drug delivery technology through twice-weekly transdermal application to treat Alzheimer's disease. A number of foreign patents have been applied for and granted to Luye Pharma to protect this product. Rivastigmine MD is presently in the registration stage in Europe and will soon begin phase III clinical research there. The deal states that Luye Pharma has given Towa exclusive rights to create and market Rivastigmine MD in Japan.
• In January 2021, Luye Pharma Group held a press conference to announce the launch of its Rivastigmine Transdermal Patch in China. The medication is approved for the treatment of mild to moderate Alzheimer's disease and should be used topically once daily. The company's German affiliate Luye Pharma AG, created the item using its unique transdermal patch technology. In addition to China, the United States, 11 nations in Europe, Thailand, and other nations have all sold Rivastigmine Transdermal Patch by Luye Pharma AG.
• In December 2019, Hisamitsu Pharmaceutical Co. Inc launched HARUROPI TAPE, a transdermal Parkinson's disease treatment patch in Japan, on December 17, 2019, following the National Health Insurance (NHI) drug price listing on November 19, 2019.

Directly Purchase a Copy of this Research Study at - https://www.theinsightpartners.com/buy/TIPRE00002894/?utm_source=OpenPR&utm_medium=10129

Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Transdermal Drug Delivery Systems Market could be worth US$ 51,949.74 Mn by 2030, says The Insight Partners here

News-ID: 3264294 • Views:

More Releases from The Insight Partners

Bread Preservatives Market Growth, Size, Share, Segmentation, Analysis By Recent Trends, Development and Growth To 2031
Bread Preservatives Market Growth, Size, Share, Segmentation, Analysis By Recent …
The Insight Partners has added Latest Report on "Bread Preservatives Market" Size To 2031. Research Report mainly includes Size, Share, growth Factors, sales, Demand, Revenue, Trade, Forecast and Global companies Analysis. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability
Complete Guide of
Complete Guide of "Private 5G Network" With Company Analysis
A private 5G network is a dedicated local area network (LAN) that expands internet connectivity for enterprise, industrial, and other users. Next-generation network services are expected to meet the demand for important wireless communication for public safety, industrial operations, and critical infrastructure connectivity as they develop. Furthermore, the global market is driven primarily by the growing demand for ultra-reliable, low-latency connections for Industrial Internet of Things (IoT) applications such as
Clinical Trial Management System Market Is Gaining Huge Growth In Upcoming Years
Clinical Trial Management System Market Is Gaining Huge Growth In Upcoming Years
The Clinical Trial Management System Market analysis entails market drivers, such as the rising number of novel chronic diseases and drug development activities, which have resulted in an increasing number of clinical trials. The increasing number of clinical trials, in turn, propels the demand for clinical trial management systems. However, the budget constraint is expected to hinder the growth of the market during the forecast period. Based on type, the
Genome Editing Market: A Guide to Understanding the Process
Genome Editing Market: A Guide to Understanding the Process
The Insight Partners has added Latest Report on "Genome Editing Market". Research Report mainly includes Size, Share, growth Factors, sales, Demand, Revenue, Trade, Forecast and Global companies Analysis. To offer more clarity regarding the industry, the report takes a closer look at the current status of various factors including but not limited to supply chain management, niche markets, distribution channel, trade, supply, and demand and production capability across different countries. Download

All 5 Releases


More Releases for Pharma

Antiemetics Market Size 2022 Analysis by Top Key Players| Acacia Pharma Group Pl …
Antiemetics Market research added by the Absolute Markets Insights, offers a comprehensive analysis of growth trends prevailing in the global business domain. This report also provides definitive data concerning market, size, commercialization aspects and revenue forecast of the industry. In addition, the study explicitly highlights the competitive status of key players within the projection timeline while focusing on their portfolio and regional expansion endeavors. Access the PDF sample of the report@
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the
Indometacin Market Top Key Manufacturers Aidarex, Ratiopharm, Merck, Xinhua Phar …
The Global Indometacin Market is a nonsteroidal anti-inflammatory drug commonly used as a prescription medication to reduce fever, pain, stiffness, and swelling from inflammation. The demand for nonsteroidal anti-inflammatory drug has been increasing owing to the emergence of anti-inflammatory biologics that are more targeted. However, such as side effects of anti-inflammatory drugs and patent expiry issues may hamper the market growth in the review period. For More Info, Get Sample Report
Hydroxycarbamide Market Study Report 2019| Taj Pharma, Beijing Jialin Pharma, Qi …
Los Angeles, United State, June 11, 2019, - The global Hydroxycarbamide market is expected to surge at a steady CAGR in the coming years, states the latest QY Research report. The publication offers an insightful take on the historical data of the market and the milestones it has achieved. The report also includes an assessment of current market trends and dynamics, which helps in mapping the trajectory of the global Hydroxycarbamide
TIGLUTIK Market 2019: Top Players are Sanofi, Mylan Pharma, Apotex, Glemark Gene …
TIGLUTIK Market 2019 Report analyses the industry status, size, share, trends, growth opportunity, competition landscape and forecast to 2025. This report also provides data on patterns, improvements, target business sectors, limits and advancements. Furthermore, this research report categorizes the market by companies, region, type and end-use industry. Get Sample Copy of this Report@ https://www.researchreportsworld.com/enquiry/request-sample/13709986 Global TIGLUTIK market 2019 research provides a basic overview of the industry including definitions, classifications, applications